Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma

European Journal of Clinical Investigation

Volumn 28, Issue 10, 1998, Pages 838-844

  Schaffler A ^a   Palitzsch, K D ^a   Seiffarth, C ^a   Hohne H M ^b   Riedhammer, F J ^b   Hofstadter F ^a   Scholmerich J ^a   Ruschoff J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b District Hospital Burglengenfeld   (Germany)

Author keywords

Hashimoto's thyroiditis; Lymphocytic thyroiditis; Microsatellite instability; Prognosis; Thyroid carcinoma; Thyroiditis

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; INFLAMMATION; IODINE DEFICIENCY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; THYROID CARCINOMA; THYROIDITIS;

ADULT; AGED; FEMALE; HUMANS; IODINE; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDITIS;

EID: 0031789965     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00363.x     Document Type: Article

References (67)

1. Holm L-E, Blomgren H, Löwhagen T. Cancer risks in patients with chronic + lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-4.
2. Hirabayashi RN, Lindsay S. The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 1965; 121: 243-52.
3. Crile G, Hazzard JB. Incidence of cancer in struma lymphomatosa. Surg Gynecol Obstet 1962; 115: 101-3.
4. Kamma H, Fujii K, Ogata T. Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 1988; 62: 1988-93.
5. Eisenberg B, Hensley SD. Thyroid cancer with coexistent Hashimoto's thyroiditis. Arch Surg 1989; 124: 1045-7.
6. Harach HR, Williams ED. Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol 1995; 43: 701-6.
7. Strauss M, Laurian N, Antebi E. Coexistent carcinoma of the thyroid gland and Hashimoto's thyroiditis. Surg Gynecol Obstet 1983; 157: 228-32.
8. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules. Surgery 1985; 98: 1202-6.
9. McKee RF, Krukowski ZH, Matheson NA. Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis. Br J Surg 1993; 80: 1303-4.
10. Segal K, Ben-Bassat M, Avraham A, Har-El G, Sidi J. Hashimoto's thyroiditis and carcinoma of the thyroid gland. Int Surg 1985; 70: 205-9.
11. McLeod MK, East ME, Burney R, Harness JK, Thompson NW. Hashimoto's thyroiditis revisited: the association with thyroid cancer remains obscure. World J Surg 1988; 12: 509-16.
12. Maceri DR, Sullivan MJ, McClatchney KD. Autoimmune thyroiditis: pathophysiology and relationship to thyroid cancer. Laryngoscope 1986; 96: 82-6.
13. Mauras N, Zimmermann D, Goellner JR. Hashimoto's thyroiditis associated with thyroid cancer in adolescent patients. J Pediatrics 1985; 106: 895-8.
14. Siegal A, Mimouni M, Kovalivker M, Griffel B. Latent childhood thyroid carcinoma in diffuse lymphocytic thyroiditis. J Surg Oncol 1983; 23: 155-7.
15. Harach HR, Escalante DA, Onativia A, Lederer-Outes J, Saravia-Day E, Williams ED. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol 1985; 108: 55-60.
16. Shull JH, Sharon N, Victor TA, Scanlon EF. Thyroid carcinoma. Immunology, irradiation, and lymphocytic infiltration. Arch Surg 1979; 114: 729-31.
17. Hofstädter F. Frequency and morphology of malignant tumor of the thyroid before and after introduction of iodine prophylaxis. Virchows Arch A Path Anat Histol 1980; 385: 263-70.
18. Williams ED, Doniach I, Bjarnason O, Michie W. Thyroid cancer in an iodine rich area. Cancer 1977; 39: 215-22.
19. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993; 365: 274-6.
20. Lothe RA, Peltomäki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-52.
21. Rüschoff J, Bocker T, Schlegel J, Stumm G, Hofstaedter F. Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 1995; 426: 215-22.
22. Peltomäki P, Aaltonen LA, Sistonen L, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993; 53: 5853-5.
23. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB, Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res 1994; 54: 2098-101.
24. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 1994; 54: 2848-51.
25. Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993; 53: 5087-9.
26. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-9.
27. Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56: 1237-40.
28. Bedi GC, Westra WH, Farzadegan H, Pitha PM, Sidransky D. Microsatellite instability in primary neoplasms from HIV+ patients. Nature Med 1995; 1: 65-8.
29. Rosai J. Atlas of tumor pathology. Tumors of the thyroid gland. AFIP 1992.
30. Schlegel J, Bocker T, Zirngibl H, Hofstädter F, Rüschoff J. Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 1995; 426: 223-7.
31. Kösel S. Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 1994; 88: 19-25.
32. Williams GH, Williams ED. Identification of tumor-specific translocations in archival material. J Pathol 1995; 175: 2279-81.
33. Greer CE, Wheeler CM, Manos MM. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Applications 1994; 8: S113-S122.
34. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fistel R, Rüschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair expression. Cancer Res 1997; 57: 4749-56.
35. Papadopoulos N, Nicolaides NC, Liu B, et al. Mutations of GTBP in genetically unstable cells. Science 1995; 268: 1915-17.
36. Honchel R, Halling KC, Schaid D, Pittelkow M, Thibodeau SN. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994; 54: 1159-63.
37. Weber JL, Kwitek AE, May PE, Wallace MR, Collins FS, Ledbetter DH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 1990; 18: 4640.
38. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991; 48: 137-44.
39. Heitz P, Moser H, Staub JJ. Thyroid cancer. Cancer 1976; 37: 2399-37.
40. Hampel R, Kühlber T, Klein K, et al. Strumaprävalenz in Deutschland gröSSer als bisher angenommen. Med Klinik 1995; 90: 324-9.
41. Schilddrüsenreport. Darmstadt: E Merck. Frankfurt/Main: GesConsultmbH 1992.
42. Quiredo A, Delange JT, Dunn RF, Benitez HK, Ibbertson DA. Definitions of endemic goiter and cretinism, classification of goiter size and severity of endemias, and survey techniques. In: Dunn, J.T. et al. Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington: Pan American Health Organization 1974: 267-272.
43. Stanbury JB. The iodine deficiency disorders: introduction and general aspects. In: Hetzel BS, Dunn JT, Stanbury JB, eds. Major Health Issues - the Prevention and Control of Iodine Deficiency Disorders. Amsterdam: Elsevier 1987: 35-48.
44. Palitzsch K-D, Schlottmann K, Arndt H, et al. Goitre prevalence in an unselected population of the Oberpfalz (Abstract). Exp Clin Endocrinol 1994; 102: 134.
45. Palitzsch K-D, Nusser J, Arndt H, et al. Pathologische Schilddrüsenveränderungen bei jungen Erwachsenen in einem Jodmangelgebiet. Med Klinik 1994; 89 (Suppl. 1): 167.
46. Belfiore A, LaRosa G, LaPorta GA. Cancer risk in patients with cold thyroidal nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992; 93: 363-9.
47. Langsteger W, Költringer P, Buchinger W, Dominik K, Binter G, Eber O. Epidemiological and etiological aspects in thyroid carcinoma. In: Pimpl W, Galvan G, Kogelnik HD, Manfreda D, eds. Struma maligna. Berlin: Springer 1993: 3-11.
48. Greenblat MS, Bennet WP, Hollstein M, Harris CC. Mutation in the p53 tumor suppressor gene: Clues to cancer aetiology and molecular pathogenesis. Cancer Res 1994; 54: 4859.
49. Zou M, Shi Y, al-Sedairy S, Hussain SS, Farid NR. The expression of the DM2gene, a p53 binding protein, in thyroid carcinogenesis. Cancer; 1995; 76: 314-8.
50. Zou MJ, Shi Y, Farid NR. p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab 1993; 77: 1054-8.
51. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid cancer. J Clin Invest 1993; 91: 179-84.
52. Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993; 17: 375-81.
53. Gerassimov G, Bronstein M, Troshina K, et al. Nuclear immunoreactivity in papillary thyroid cancer is associated with two established indicators of poor prognosis. Exp Mol Pathol 1995; 62: 52-62.
54. Jennings T, Bratslavsky G, Gerasimov G, et al. Nuclear accumulation of MDM2 protein, in well-differentiated papillary thyroid carcinomas. Exp Mol Pathol 1995; 62: 199-206.
55. Hamilton SR, Liu B, Parsons E, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1994; 332: 839-47.
56. Rustgi AK. Hereditary gastrointestinal polyposis and polyposis syndrome. N Engl J Med 1995; 331: 1694-702.
57. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and whit and African Americans. Cancer 1995; 76: 2312-8.
58. Sclafani AP, Valdes M, Cho H. Hashimoto's thyroiditis and carcinoma of the thyroid: optimal management. Laryngoscope 1993; 103: 845-9.
59. Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J. Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinct low-grade malignancy arising from the metaplastic follicles of Hashimoto's thyroiditis. Am J Surg Pathol 1991; 15: 438-48.
60. Aho K, Gordin A, Palosuo T, Takala J. Development of thyroid autoimmunity. Acta Endocrinol 1985; 108: 61-4.
61. Amino N, Pysher T, Cohen E, Degroot L. Immunologic aspects of human thyroid cancer. Cancer 1975; 36: 963-73.
62. Meier BW. Parenchymal findings in thyroidal carcinoma; pathologic study of 256 cases. J Clin Endocrinol Metab 1959; 19: 162-71.
63. Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y. Papillary carcinoma of the thyroid. Tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 20: 695-8.
64. Privalov VA, Saprykin AA. Characteristics of thyroid cancer in combination with autoimmune thyroiditis. Vestn-Khir 1986; 136: 53-6.
65. Williams ED, Doniach I. The post-mortem incidence of focal thyroiditis. J Path Bact 1962; 83: 255-64.
66. Haapala A-M, Soppi E, Mörsky P, Salmi J, Laine S, Mattila J. Thyroid antibodies in association with thyroid malignancy. APMIS 1994; 102: 390-4.
67. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 1989; 13: 1041-9.